Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Regulatory T cells can help treat diseases, and a stem cell solution may improve hair growth.

Blocking LFA-1 prevents hair loss in mice.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Special cells can help regrow hair in alopecia areata.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

10-20% of mouse Tregs have dual TCRs, suggesting potential functional benefits.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Regulatory T cells help control the immune system and could lead to new treatments for diseases.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

Prostanoids help regulate immune cells, affecting inflammation and cancer.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Hair follicle stem cells help heal wounds by turning certain immune cells into ones that reduce inflammation.

Impaired regulatory T cells worsen psoriasis, but treatments can help restore balance.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Dual TCR Treg cells are common in mouse tissues and vary by location.